PerkinElmer announces availability of HER2Sense preclinical imaging agent

[News]

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.

More... (http://www.news-medical.net/news/20120403/PerkinElmer-announces-availability-of-HER2Sense-preclinical-imaging-agent.aspx)